Related Experiment Video
Updated: May 28, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
[Proteins influencing the blood coagulation]
1Universitätsklinik für Hämatologie und Hämatologisches Zentrallabor, Inselspital, Universitätsspital und Universität Bern. lorenzo.alberio@insel.ch
This review covers natural proteins and drugs that modulate blood coagulation, including factors like von Willebrand factor and protein C. It details treatments for bleeding and coagulopathy, and discusses recombinant anticoagulants.
Area of Science:
- Hematology
- Biochemistry
- Pharmacology
Background:
- The coagulation system is crucial for hemostasis.
- Dysregulation of coagulation can lead to bleeding or thrombosis.
- Therapeutic modulation of coagulation proteins is essential in various clinical scenarios.
Purpose of the Study:
- To review natural proteins and pharmacological agents that modulate the coagulation system.
- To discuss the biochemical characteristics and physiological roles of key coagulation factors.
- To detail clinical applications in managing bleeding and coagulopathies.
Main Methods:
- Literature review of natural proteins and pharmacological compounds.
- Discussion of biochemical properties and physiological roles.
- Analysis of clinical applications and treatment strategies.
Main Results:
- Identified key coagulation proteins (von Willebrand factor, extrinsic/intrinsic factors, protein C).
- Detailed available treatments including factor concentrates, desmopressin, and protein C concentrate.
- Highlighted applications in massive bleeding, vitamin K antagonist reversal, and meningococcemia-induced coagulopathy.
- Described recombinant anticoagulants lepirudin and bivalirudin.
Conclusions:
- A range of plasma-derived and recombinant therapies can modulate the coagulation system.
- Understanding these agents is vital for managing complex hemostatic disorders.
- Pharmacological interventions offer critical treatment options for bleeding and coagulopathy.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...